Comments on: My take: NPs, solving health care, generics vs brand name drugs http://www.kevinmd.com/blog/2008/03/my-take-2.html medical blog Sun, 22 Nov 2009 07:50:13 -0500 http://wordpress.org/?v=2.8.4 hourly 1 By: Anonymous http://www.kevinmd.com/blog/2008/03/my-take-2.html/comment-page-1#comment-84918 Anonymous Wed, 09 Apr 2008 16:20:00 +0000 http://clients.emmense.com/kevinmd/2008/03/my-take-nps-solving-health-care-generics-vs-brand-name-drugs.html#comment-84918 I would much rather see an NP then a physcian, They have the ability to nursing diagnose and to medically diagnose and are much more intune and compassionate to the patient. I have no doubt in their ability they are well prepared and have to pass state boards and know what they are doing to practice. They also are trained in the particular specialty that they are practicing in. Thank God for NP's. I would much rather see an NP then a physcian, They have the ability to nursing diagnose and to medically diagnose and are much more intune and compassionate to the patient. I have no doubt in their ability they are well prepared and have to pass state boards and know what they are doing to practice. They also are trained in the particular specialty that they are practicing in. Thank God for NP’s.

]]> By: esilverman http://www.kevinmd.com/blog/2008/03/my-take-2.html/comment-page-1#comment-84305 esilverman Wed, 19 Mar 2008 15:24:00 +0000 http://clients.emmense.com/kevinmd/2008/03/my-take-nps-solving-health-care-generics-vs-brand-name-drugs.html#comment-84305 Hi Kevin,<br/><br/>Is pharma behind this? That's what the GPHA has been saying. Is that true? That's another matter. But here's something interesting...<br/><br/>As I pointed out at Pharmalot, two of the three docs who are quoted by the LA Times as being skeptical of generics both have ties to brand-name drugmakers, although the paper doesn’t point this out. For a November 2006 CME presentation, Kowey disclosed he is a consultant or an adivsory board member for AstraZeneca, Glaxo, Procter & Gamble, Sanofi-Aventis, Solvay and Wyeth. And Gerald Naccarelli, chief of Pennsylvania State medical center’s division of cardiology, has a long list of fees he has accepted from Pfizer, Sanofi-Aventis, Glaxo and Wyeth, among others.<br/><br/>Ed S at Pharmalot<br/><br/>http://www.pharmalot.com/2008/03/are-generics-as-good-as-brand-name-meds/ Hi Kevin,

Is pharma behind this? That’s what the GPHA has been saying. Is that true? That’s another matter. But here’s something interesting…

As I pointed out at Pharmalot, two of the three docs who are quoted by the LA Times as being skeptical of generics both have ties to brand-name drugmakers, although the paper doesn’t point this out. For a November 2006 CME presentation, Kowey disclosed he is a consultant or an adivsory board member for AstraZeneca, Glaxo, Procter & Gamble, Sanofi-Aventis, Solvay and Wyeth. And Gerald Naccarelli, chief of Pennsylvania State medical center’s division of cardiology, has a long list of fees he has accepted from Pfizer, Sanofi-Aventis, Glaxo and Wyeth, among others.

Ed S at Pharmalot

http://www.pharmalot.com/2008/03/are-generics-as-good-as-brand-name-meds/

]]> By: The Hospital Pharmacist http://www.kevinmd.com/blog/2008/03/my-take-2.html/comment-page-1#comment-84301 The Hospital Pharmacist Wed, 19 Mar 2008 13:29:00 +0000 http://clients.emmense.com/kevinmd/2008/03/my-take-nps-solving-health-care-generics-vs-brand-name-drugs.html#comment-84301 I would love to see some actual research on the brand vs. generic issue. All I have seen so far is anecdotal evidence. <br/>I personally take generics, and recommend generics when available, unless it is a Narrow Therapeutic Index drug. Then, it's brand all the way. I would love to see some actual research on the brand vs. generic issue. All I have seen so far is anecdotal evidence.
I personally take generics, and recommend generics when available, unless it is a Narrow Therapeutic Index drug. Then, it’s brand all the way.

]]> By: Carol http://www.kevinmd.com/blog/2008/03/my-take-2.html/comment-page-1#comment-84298 Carol Wed, 19 Mar 2008 01:00:00 +0000 http://clients.emmense.com/kevinmd/2008/03/my-take-nps-solving-health-care-generics-vs-brand-name-drugs.html#comment-84298 Generics: I am very happy to use them for antibiotics or pain meds. But for things like hypothyroid or seizure meds, I would stay with name brands because they require such careful and steady dosages. Just my personal choice. <br/><br/>Also - if I go to see a doctor I want to see a doctor not a nurse, regardless of the level of nursing education. Generics: I am very happy to use them for antibiotics or pain meds. But for things like hypothyroid or seizure meds, I would stay with name brands because they require such careful and steady dosages. Just my personal choice.

Also – if I go to see a doctor I want to see a doctor not a nurse, regardless of the level of nursing education.

]]> By: Throckmorton http://www.kevinmd.com/blog/2008/03/my-take-2.html/comment-page-1#comment-84294 Throckmorton Tue, 18 Mar 2008 20:09:00 +0000 http://clients.emmense.com/kevinmd/2008/03/my-take-nps-solving-health-care-generics-vs-brand-name-drugs.html#comment-84294 I am not sure about the role of ANRPs in the healthcare crisis. I say this as we have seen a huge increase in the number of specialist referrals for what would otherwise been handled at the PCP level. This has created even higher utilization of specialists and the over all loss of the role of the primary care physician. Where the internist and family physician are able to manage the overall health of the patient, the ANRPs tend to be tour guides sending patients off to see specialists with no overall medical management. <br/><br/>I had a classic example of this yesterday. A patient needed medical clearance or at least an overall picture of his medical conditions prior to cancer surgery. When I called his PCP I found that it was an ANRP. I asked about his overall medical stability and she had no idea and suggested that I call his endocrinologist, cardiologist and his gastroenterologist I am not sure about the role of ANRPs in the healthcare crisis. I say this as we have seen a huge increase in the number of specialist referrals for what would otherwise been handled at the PCP level. This has created even higher utilization of specialists and the over all loss of the role of the primary care physician. Where the internist and family physician are able to manage the overall health of the patient, the ANRPs tend to be tour guides sending patients off to see specialists with no overall medical management.

I had a classic example of this yesterday. A patient needed medical clearance or at least an overall picture of his medical conditions prior to cancer surgery. When I called his PCP I found that it was an ANRP. I asked about his overall medical stability and she had no idea and suggested that I call his endocrinologist, cardiologist and his gastroenterologist

]]> By: Ian Furst http://www.kevinmd.com/blog/2008/03/my-take-2.html/comment-page-1#comment-84292 Ian Furst Tue, 18 Mar 2008 19:57:00 +0000 http://clients.emmense.com/kevinmd/2008/03/my-take-nps-solving-health-care-generics-vs-brand-name-drugs.html#comment-84292 Check out the review of primary care in Ontario at<br/>http://www.ices.on.ca/webpage.cfm?site_id=1&org_id=67&morg_id=0&gsec_id=0&item_id=3655&type=atlas<br/>it's a lengthy document but goes though the state of primary care in Ontario and our GP population. Of note 1/3 of all men between 20-39 do not see a doctor each year. I'm not sure if this helps or hurts the argument for guys like Dr. but I'm sure it adds to the workload after 40 and is related to the shortage of GP's. The meat of the articles is found on page 2 of Chapter 4<br/>http://www.ices.on.ca/file/PC_atlas_chapter4.pdf<br/>A greater proportion of patients are seeing specialists for diseases like CHF and do better if they do. While NP's and generic drugs may help I don't think they're the answer based on this evidence. What about group practice with specialists and GP's with pay-per-patient rather than fee-for-service? It would streamline care significantly and increase access for patients. <br/>Happy reading. <br/>Ian.<br/><a HREF="http://www.waittimes.blogspot.com/" REL="nofollow">www.waittimes.blogspot.com</a> Check out the review of primary care in Ontario at
http://www.ices.on.ca/webpage.cfm?site_id=1&org_id=67&morg_id=0&gsec_id=0&item_id=3655&type=atlas
it’s a lengthy document but goes though the state of primary care in Ontario and our GP population. Of note 1/3 of all men between 20-39 do not see a doctor each year. I’m not sure if this helps or hurts the argument for guys like Dr. but I’m sure it adds to the workload after 40 and is related to the shortage of GP’s. The meat of the articles is found on page 2 of Chapter 4
http://www.ices.on.ca/file/PC_atlas_chapter4.pdf
A greater proportion of patients are seeing specialists for diseases like CHF and do better if they do. While NP’s and generic drugs may help I don’t think they’re the answer based on this evidence. What about group practice with specialists and GP’s with pay-per-patient rather than fee-for-service? It would streamline care significantly and increase access for patients.
Happy reading.
Ian.
http://www.waittimes.blogspot.com

]]>